A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with ...

A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with metastatic colorectal cancer.

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

RECKGIST score may predict recurrence in neurofibromatosis type 1 GISTs, potentially guiding treatment decisions, according ...

1 Department of Pharmacology, The First People’s Hospital of Yancheng, Yancheng, Jiangsu, China 2 Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu, China ...

Just two servings of yogurt a week may protect the bowels from some specific types of cancer, according to a new long-term study in the US. For years now, scientists have suspected yogurt and its ...

In recent years, the tumor microenvironment in gastrointestinal cancer has emerged as a focal point of research due to its indispensable role in tumor initiation, progression, and metastasis. This ...

The European Society for Medical Oncology (ESMO) guidelines recommend life-long systemic tyrosine kinase inhibitor (TKI) therapies for advanced gastrointestinal stromal tumours (GIST), in order to ...

Cancer arises as an enemy from within. One of the body’s own cells becomes damaged or corrupted and then multiplies to create copies of its aberrant self. The ballooning army of deviant cells ...

Gastrointestinal bleeding ... that patients with gastric GIST bleeding had significantly worse prognoses, while the bleeding risk in the small intestine was lower,” Bai continued. GISTs are common ...